NMC warns of 'Fake' Notice on NExT Syllabus, Marks Distribution

Published On 2022-02-06 04:00 GMT   |   Update On 2022-02-06 04:00 GMT
Advertisement

New Delhi: In a recent public notice, the Ethics & Medical Registration Board of the National Medical Commission has warned about a fake notice claiming to contain information regarding the upcoming National Exit Test (NEXT).

The notice, which has been termed to be a fake by NMC, claims to contain information regarding the new syllabus of the National Exit Test. Apart from that, the notice also mentioned the Subject wise marks distribution in the test.

Advertisement

It was also claimed in the notice that "NEXT-1 will be conducted on December 2022."

"As per the new guidelines of National Medical Commission the subjects and marks distribution regarding NEXT will be now changed and candidate have to follow new structure as per following," mentioned the fake notice.

Also Read: Shocking allegations claim fake PG Degree by ex-NMC Secretary Dr R K Vats, Complainant Questions Delayed Probe

Regarding the National Exist Test Syllabus, the notice claimed, "All 19 subjects in new MCI curriculum will be included in NEXT exit test syllabus for MBBS, But subject-wise marks distribution will be drastically different than what it was in NEET-PG exam on MCI Screening exam (i.e. FMGE Foreign Medical Graduate Examiantion), The clinical subjects will carry disproportionately more marks than pre- & para-clinical subjects."

In the fake notice, it was claimed that in the new paper pattern, there would be 55 marks of MCQ in Medicine (allied subjects-Dermatology, Psychiatry), 60 in Surgery (Orthopedics, Anesthesia), 60 in Obs & Gyn (Radiology). Apart from this, MCQ containing 25 marks in Minor subject Pediatrics, 20 each in ENT and Opthalmology will also be there in the new paper pattern.

So, altogether there would be total number of 240 MCQs including 175 from Major subjects and 65 from Minor subjects.

"Each correct answer in NEXT, 4 marks will be awarded and one mark will be deducted for each wrong attempt. If any candidate will leave the question un-attempted, there is no negative marking or that," mentioned the notice regarding marking scheme for NEXT-1.

However, clarifying that the notice is a 'fake', NMC has mentioned in its public notice dated 04.02.2022, "It is informed to all that the document is fake and is not issued by EMRB (NMC). All concerned may kindly take notice of this."

There are several speculations regarding the much awated NEXT examination, which is going to serve not only as a licentiate exam for those who have done MBBS in India as well as abroad but would also serve as a gateway to admission to the postgraduate broad-speciality medical education in the country. The exam is going to be attempted by Indian medical graduates and foreign medical graduates (FMGs) alike, thus providing a level playing field for all to practice in the country.

Although there is not much clarity regarding the exam yet, Medical Dialogues had earlier reported that some insights were given regarding the exam in a recent study by the members of the Undergraduate Medical Education Board of the National Medical Commission (NMC). The study has been published in The National Medical Journal of India with the title "Seeking graduation in medical colleges outside India: Is it a 'win–win situation' or 'lose–lose situation' for the stakeholders and the nation?"
As per the paper, which has been authored by the members of UGMEB, the NEXT examination would be conducted in two parts- NEXT Step 1 and NEXT Step 2. While NEXT 1 wil be a theroy exam on the basis of multiple-choice questions, NEXT Step 2 will test the practical knowledge of the students.

Click on the link below to view the notice:  

https://www.nmc.org.in/fakeletternotissuedbynmc

Also Read: A sneak peak into NEXT exam

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News